Partner study description

A prospective study designed to identify molecular markers of antimalarial drug resistance in Plasmodium falciparum in Yola, Nigeria. Objectives of the study are:

1. To detect clinically significant genes associated with antimalarial drug resistance in Plasmodium falciparum using dried blood spot (DBS) samples
2. To calculate the parasite density in patients who are malaria rapid diagnostic test (RDT) positive
3. To determine the rate of malaria infection among febrile patients presenting to the hospital
4. To determine if an infection comprises additional species of Plasmodium, such as P. vivax, P. malariae, P. ovale, and P. knowlesi
5. To assess the use of malaria control interventions.